Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records-Reference-Cited by-同舟云学术

Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records

Published:2021-08-28 Issue:5 Volume:11 Page:1733-1749
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Armstrong April W.,Patil Dhaval,Levi Eugenia,McGuiness Catherine B.,Wang Xin,Wang Yi,Chen Chi-Chang,Nguyen Elizabeth,Yamauchi Paul S.

Funder

novartis pharmaceuticals corporation

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13555-021-00599-5.pdf

Reference34 articles.

1. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–6. https://doi.org/10.1016/j.jaad.2013.11.013.

2. Gottlieb A, Korman NJ, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851–64. https://doi.org/10.1016/j.jaad.2008.02.040.

3. Palfreeman AC, McNamee KE, McCann FE. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast. Drug Des Devel Ther. 2013;7:201–10. https://doi.org/10.2147/DDDT.S32713.

4. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med. 2009;122(12):1150.e1-9. https://doi.org/10.1016/j.amjmed.2009.06.021.

5. Schaefer CP, Cappelleri JC, Cheng R, et al. Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States. J Am Acad Dermatol. 2015;73(4):585-93.e3. https://doi.org/10.1016/j.jaad.2015.06.049.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory;International Journal of Molecular Sciences;2024-05-31

2. Real‐world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety;Dermatologic Therapy;2022-11-16

3. Outcome measures in psoriatic arthritis: Where next?;Musculoskeletal Care;2022-11

4. Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting;Journal of Dermatological Treatment;2022-09-05

5. Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting;Dermatology and Therapy;2022-05-13